Shares of Advanced Oncotherapy PLC (LON:AVO) crossed below its fifty day moving average during trading on Friday . The stock has a fifty day moving average of $40.96 and traded as low as $37.45. Advanced Oncotherapy shares last traded at $39.52, with a volume of 81,659 shares changing hands.
The company has a debt-to-equity ratio of 8.83, a quick ratio of 0.21 and a current ratio of 1.53. The firm’s 50 day simple moving average is GBX 40.88. The firm has a market capitalization of $80.17 million and a price-to-earnings ratio of -2.86.
Advanced Oncotherapy Company Profile (LON:AVO)
Advanced Oncotherapy PLC, together with its subsidiaries, focuses on providing radiotherapy systems for the treatment of cancer. The company operates through two segments, Proton Therapy and Healthcare Related Properties. It is developing Linac Image Guided Hadron Technology, a proton therapy system for treating cancer.
Further Reading: What is Call Option Volume?
Receive News & Ratings for Advanced Oncotherapy Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Advanced Oncotherapy and related companies with MarketBeat.com's FREE daily email newsletter.